A double-blind, randomized, crossover trial protocol of whole hemp seed protein and hemp seed protein hydrolysate consumption for hypertension.
- 2020-04-23
- RCT
- Trials 21(1)
- Maryam Samsamikor
- Dylan Mackay
- Rebecca C Mollard
- Rotimi E Aluko
- PubMed: 32326966
- DOI: 10.1186/s13063-020-4164-z
- High evidence
- Clinical
This trial protocol is designed to evaluate the hypotensive potential of consuming whole HSP, and HSP+, in comparison to casein protein.
- Effect
- Neutral
- Effect size
- Small
- Significant
- No
- Dose
- 25 g twice a day